Molecule intelOpportunity: ModerateEssentialCrowded market

Isoniazid

142 brands · 48 companies · product forms

ATC: J04AC01

Opportunity snapshot

Launch attractiveness
35
Market saturation
98
Price room
100
Regulatory risk
0
142
brands
48
companies
Rs 605.1
median price
57
price points
959.09x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 11%

Price room

Across observed sources and strengths
CheapestRs 6.68
MedianRs 605.1
Most expensiveRs 6,406.7
Spread959.09×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 959.09x across 57 trusted points (Rs 6.68-6406.7). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 11 live products for Isoniazid — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(2) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

48 canonical companies and 142 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 959.09x across 57 trusted points (Rs 6.68-6406.7). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.